Coming soon
Lean Metabolic
No availability date confirmed. Get updates and explore currently available care options.
Join the email listFormBlends care & research
Find your care
Current offers
7 bundles in this view
Start hereRecovery
Save 15%Bundle
Repair & RecoverTissue repair paired with skin and collagen support.
BPC-157GHK-Cu (Copper Peptide)
$707$924Save $217
3-month plan · ships quarterly
Plan length
Pay every 3 months · Ships every 3 months
Immune
Save 15%Bundle
Immune DefenseImmune modulation with antimicrobial support.
Thymosin Alpha-1LL-37
$936$1224Save $288
3-month plan · ships quarterly
Plan length
Pay every 3 months · Ships every 3 months
Longevity
Save 15%Bundle
Longevity ResetTelomere support with the master antioxidant.
Epithalon (Epitalon)Glutathione Injectable
$615$804Save $189
3-month plan · ships quarterly
Plan length
Pay every 3 months · Ships every 3 months
Sleep
Save 15%Bundle
Sleep & RestoreDeep-sleep signaling paired with overnight recovery.
DSIP (Delta Sleep-Inducing Peptide)Sermorelin
$730$954Save $224
3-month plan · ships quarterly
Plan length
Pay every 3 months · Ships every 3 months
Energy
Save 15%Bundle
Cellular EnergyCellular fuel paired with mitochondrial output.
NAD+ Peptide ComplexMOTS-c
$890$1164Save $274
3-month plan · ships quarterly
Plan length
Pay every 3 months · Ships every 3 months
Detox
Save 15%Bundle
Recharge & DetoxCellular recharge paired with the master antioxidant.
NAD+ Peptide ComplexGlutathione Injectable
$569$744Save $175
3-month plan · ships quarterly
Plan length
Pay every 3 months · Ships every 3 months
Editorial update
How to compare product options
Shoppers comparing FormBlends GLP-1 programs, peptide bundles, and research profiles need a direct answer on fit first, then the evidence, timeline, and provider-review details that change the decision.
Answer who qualifies, what it costs, what forms exist, common side effects, and which alternatives to compare.
Put the practical answer near the top before the commercial call to action.
Link to dosing, safety, cost, and comparison guides that support the decision.
Finder facts for search and AI answers
What this product finder answers
Catalog scope
0 product and research profiles across 6 goal lanes
The finder organizes GLP-1 programs, peptide research profiles, blends, and goal-based comparison paths.
Clinical access
0 GLP-1 program profiles in this view
GLP-1 treatment paths require licensed-provider review for eligibility, contraindications, dosing, and side-effect management.
Research status
0 watchlist or research-only profiles in this view
Research/watchlist pages should not be treated as ordinary patient access pages.
Decision role
Compare goal fit, evidence strength, mechanism, timeline, and next step
The finder should route users into the right product page rather than making every product look equivalent.
Start by goal
What are you trying to improve?
Each lane groups profiles by the outcome people most often compare first: weight loss, recovery, performance, appearance, cognition, or rest.
6 profiles
Most requested
Lose weight
Compare the GLP-1 programs and metabolic profiles with the clearest outcome data.
Explore lane
6 profiles
High intent
Recover faster
Explore tendon, ligament, muscle, gut, and inflammation research profiles.
Explore lane
11 profiles
Compare stacks
Build performance
Browse growth hormone, IGF-1, and body-composition pathway research.
Explore lane
5 profiles
Visual category
Look better
Scan skin, hair, copper peptide, collagen, and visible-aging profiles.
Explore lane
7 profiles
Brain health
Think clearer
Compare cognitive, focus, calm, and neuroprotection research profiles.
Explore lane
5 profiles
Recovery rhythm
Sleep and reset
Find sleep, stress, recovery rhythm, and nervous-system support profiles.
Explore lane
Most compared
Semaglutide vs Tirzepatide
SURMOUNT evidenceUp to 22.5% mean loss
Compounded Tirzepatide
Usually the strongest comparison page for people choosing between GLP-1 options and prioritizing top-line results.
22.5%
Mean weight loss
63%
Lost 20% or more
Dual
Receptor pathway
STEP 1 evidenceUp to 14.9% mean loss
Compounded Semaglutide
Often the best starting point when you want proven GLP-1 appetite control before comparing stronger dual-agonist options.
14.9%
Mean weight loss
86.4%
Lost at least 5%
Weekly
Treatment rhythm